Q1 2013 Earnings Call
August 21, 2012 8:00 am ET
Omar S. Ishrak - Chairman and Chief Executive Officer
Gary L. Ellis - Chief Financial Officer, Principal Accounting Officer and Senior Vice President
Michael J. Coyle - Executive Vice President and Group President of Cardiac & Vascular Group
Christopher J. O'Connell - Executive Vice President and Group President of Restorative Therapies Group
Matthew J. Dodds - Citigroup Inc, Research Division
Michael N. Weinstein - JP Morgan Chase & Co, Research Division
David R. Lewis - Morgan Stanley, Research Division
Kristen M. Stewart - Deutsche Bank AG, Research Division
Rajeev Jashnani - UBS Investment Bank, Research Division
Robert A. Hopkins - BofA Merrill Lynch, Research Division
Topher Orr - Goldman Sachs Group Inc., Research Division
Bruce M. Nudell - Crédit Suisse AG, Research Division
Joshua T. Jennings - Cowen and Company, LLC, Research Division
Derrick Sung - Sanford C. Bernstein & Co., LLC., Research Division
Joanne K. Wuensch - BMO Capital Markets U.S.
Good morning. My name is Christie, and I will be your conference operator today. At this time, I would like to welcome everyone to the Medtronic's First Quarter Earnings Release Conference Call. [Operator Instructions] Thank you. It is now my pleasure to hand the program over to Mr. Jeff Warren. Please go ahead.
Thank you, Christie. Good morning, and welcome to Medtronic's First Quarter Conference Call and Webcast. During the next hour, Omar Ishrak, Medtronic Chairman and Chief Executive Officer; and Gary Ellis, Medtronic Chief Financial Officer, will provide comments on the results of our fiscal year 2013 first quarter, which ended July 27, 2012. After our prepared remarks, we will be happy to take your questions.